Karen Nash
Karen Nash is a medical reporter and media consultant based in Monroeville, PA.
Do you think shock wave lithotripsy should be retired?
Despite ureteroscopy's high success results, there is still a role for shock wave lithotripsy in treating stones, urologists say.
Are you seeing a decline in PSA screening?
"We’re definitely seeing fewer men referred for elevated PSAs," one urologist told Urology Times.
What’s been your experience with ICD-10 so far?
What’s been your experience with ICD-10 so far?
Three urologists discussing their early experiences with ICD-10 make it clear that the transition hasn't been the disaster predicted by some.
What would you like to change about how you practice urology?
Urologists lament how prior authorization and EHRs take them away from their patients.
What’s your reaction to CVS/Caremark dropping coverage of Viagra?
"I don’t think the CVS action will damage Viagra that much. They’ll find a way to get it to the market. It might even put some price pressure on Viagra, which could actually be a good thing," one urologist said.
How is your practice affected by prior authorizations?
"Over the past 10 years, it’s been getting progressively more challenging to schedule certain tests and treatments because of insurance companies’ hoops that we have to go through," says one urologist.
What’s your opinion on targeted biopsy for prostate cancer?
“It is a positive thing, because the technology we’re using now is not really very accurate," one urologist told Urology Times.
What’s your opinion on targeted biopsy for prostate cancer?
“It is a positive thing, because the technology we’re using now is not really very accurate," one urologist told Urology Times.
What do you think of new warning labels on TRT products?
What do you think of new warning labels on TRT products?
“The FDA is being very cautious, which as the protector of public health, it’s got to be," says one urologist.

Poll